These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26687555)

  • 1. Mechanical Reinforcement of Proteins with Polymer Conjugation.
    DeBenedictis EP; Hamed E; Keten S
    ACS Nano; 2016 Feb; 10(2):2259-67. PubMed ID: 26687555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence and Conformational Analysis of Peptide-Polymer Bioconjugates by Multidimensional Mass Spectrometry.
    Sallam S; Dolog I; Paik BA; Jia X; Kiick KL; Wesdemiotis C
    Biomacromolecules; 2018 May; 19(5):1498-1507. PubMed ID: 29554423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ethylene glycol) conjugation stabilizes the secondary structure of α-helices by reducing peptide solvent accessible surface area.
    Hamed E; Xu T; Keten S
    Biomacromolecules; 2013 Nov; 14(11):4053-60. PubMed ID: 24032457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry for peptide and protein PEGylation.
    Roberts MJ; Bentley MD; Harris JM
    Adv Drug Deliv Rev; 2002 Jun; 54(4):459-76. PubMed ID: 12052709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helix stabilization of poly(ethylene glycol)-peptide conjugates.
    Jain A; Ashbaugh HS
    Biomacromolecules; 2011 Jul; 12(7):2729-34. PubMed ID: 21657254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-polymer conjugation-moving beyond PEGylation.
    Qi Y; Chilkoti A
    Curr Opin Chem Biol; 2015 Oct; 28():181-93. PubMed ID: 26356631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
    Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
    Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
    Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of PEGylation on the Strength of Protein Surface Salt Bridges.
    Xiao Q; Draper SRE; Smith MS; Brown N; Pugmire NAB; Ashton DS; Carter AJ; Lawrence EEK; Price JL
    ACS Chem Biol; 2019 Jul; 14(7):1652-1659. PubMed ID: 31188563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylation, successful approach to drug delivery.
    Veronese FM; Pasut G
    Drug Discov Today; 2005 Nov; 10(21):1451-8. PubMed ID: 16243265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylation: an approach for drug delivery. A review.
    Jain A; Jain SK
    Crit Rev Ther Drug Carrier Syst; 2008; 25(5):403-47. PubMed ID: 19062633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation of native disulfide bonds in proteins.
    Brocchini S; Balan S; Godwin A; Choi JW; Zloh M; Shaunak S
    Nat Protoc; 2006; 1(5):2241-52. PubMed ID: 17406463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylation within a confined hydrophobic cavity of a protein.
    Munasinghe A; Mathavan A; Mathavan A; Lin P; Colina CM
    Phys Chem Chem Phys; 2019 Nov; 21(46):25584-25596. PubMed ID: 31720639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene Glycol Based Changes to β-Sheet Protein Conformational and Proteolytic Stability Depend on Conjugation Strategy and Location.
    Draper SRE; Lawrence PB; Billings WM; Xiao Q; Brown NP; Bécar NA; Matheson DJ; Stephens AR; Price JL
    Bioconjug Chem; 2017 Oct; 28(10):2507-2513. PubMed ID: 28972368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation and HAylation via catechol: α-Amine-specific reaction at N-terminus of peptides and proteins.
    Song IT; Lee M; Lee H; Han J; Jang JH; Lee MS; Koh GY; Lee H
    Acta Biomater; 2016 Oct; 43():50-60. PubMed ID: 27424082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Product development issues for PEGylated proteins.
    Payne RW; Murphy BM; Manning MC
    Pharm Dev Technol; 2011 Oct; 16(5):423-40. PubMed ID: 20858059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent conjugation of poly(ethylene glycol) to proteins and peptides: strategies and methods.
    Mero A; Clementi C; Veronese FM; Pasut G
    Methods Mol Biol; 2011; 751():95-129. PubMed ID: 21674328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of PEGylation on Host Defense Peptide Complexation with Bacterial Lipopolysaccharide.
    Ilyas H; van der Plas MJA; Agnoletti M; Kumar S; Mandal AK; Atreya HS; Bhunia A; Malmsten M
    Bioconjug Chem; 2021 Aug; 32(8):1729-1741. PubMed ID: 34282895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for selecting PEGylation sites on proteins for higher thermodynamic and proteolytic stability.
    Lawrence PB; Gavrilov Y; Matthews SS; Langlois MI; Shental-Bechor D; Greenblatt HM; Pandey BK; Smith MS; Paxman R; Torgerson CD; Merrell JP; Ritz CC; Prigozhin MB; Levy Y; Price JL
    J Am Chem Soc; 2014 Dec; 136(50):17547-60. PubMed ID: 25409346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.